Stocks
Themes
Market Cap Ranking
Trading Strategies
SEC Filings TLDR
Analysis Reports
Sign in
Loading stock data...
Loading updates and signals...
Back
CLDI
$1.57
+8.28%
Analyze
1M
+0.6%
3M
+441.4%
1Y
+33.1%
Market Cap:
$8.40M
Calidi Biotherapeutics Inc.
Healthcare |
Biotechnology
Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer. The company is headquartered in San Diego, California.
Click "Analyze" to generate stock analysis
CLDI Price Trend and Signals
CLDI Financials
Signals
News
SEC Filings
Holders
Research Reports
AI Analysis
2025-09-25
Somewhat Bearish
price_signal
Monthly low detected.
2025-09-22
Bullish
macd_signal
Golden cross below zero detected.
2025-09-19
Somewhat Bearish
price_signal
Monthly low detected.